See every side of every news story

Published 4 hours ago • loading... • Updated 2 minutes ago

Yicura BioMed Advances Dual Capital and Industrial Strategy： Completes First Closing of Series B Financing Led by Gobi Partners

Summary by The Manila Times

Advancing Core Product ICVAX® for HIV & Immunotherapy Pipeline for Cancers

7 Articles

7 Articles

Yicura BioMed Advances Dual Capital and Industrial Strategy： Completes First Closing of Series B Financing Led by Gobi Partners | Taiwan News | Nov. 13, 2026 13:15

Nov. 13, 2026 13:15

2 minutes ago·Taipei City, Taiwan

Read Full Article

The Manila Times

+4 Reposted by 4 other sources

Yicura BioMed Advances Dual Capital and Industrial Strategy： Completes First Closing of Series B Financing Led by Gobi Partners

Advancing Core Product ICVAX® for HIV & Immunotherapy Pipeline for Cancers

3 hours ago·Manila, Philippines (the)

Read Full Article

TechNode Global

Yicura BioMed closes first tranche of Series B led by Gobi Partners

Hong Kong clinical-stage biotech Yicura BioMed has completed the first closing of a Series B led by Gobi Partners, with the amount undisclosed.

20 minutes ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources7

Leaning Left1Leaning Right1Center0Last Updated60 seconds agoBias Distribution

50% Left, 50% Right

Bias Distribution

50% of the sources lean Left, 50% of the sources lean Right

50% Right

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The InfoStride broke the news 4 hours ago on Friday, November 13, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics